NSEDCP
NXTM

NJ State Employees Deferred Compensation Plan’s NxStage Medical Inc. NXTM Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,000
Closed -$335K – 550
2018
Q3 		$335K Sell
12,000
-12,000
-50% -$337K 0.06% 413
2018
Q2 		$670K Sell
24,000
-20,000
-45% -$536K 0.12% 219
2018
Q1 		$1.09M Buy
44,000
+8,000
+22% +$195K 0.19% 122
2017
Q4 		$872K Buy
+36,000
New +$948K 0.15% 185

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's NXTM Position: Q4 2018 in Review

NJ State Employees Deferred Compensation Plan sold out of NxStage Medical Inc. (NXTM) in Q4 2018, closing a stake of 12,000 shares — an estimated $335K sold.

NJ State Employees Deferred Compensation Plan first reported a position in NXTM in Q4 2017 and held it in 4 quarters. The position peaked at $1.09M in Q1 2018. 172 funds tracked by Wall St. Rank hold NXTM as of Q4 2018.

  • NJ State Employees Deferred Compensation Plan reported no remaining NxStage Medical Inc. position as of Q4 2018 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 12,000 NxStage Medical Inc. shares in Q4 2018, an estimated $335K.
  • NJ State Employees Deferred Compensation Plan first reported a position in NxStage Medical Inc. in Q4 2017 and held it in 4 quarters.
  • NJ State Employees Deferred Compensation Plan's NxStage Medical Inc. position peaked at $1.09M in Q1 2018.
  • 172 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2018.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2018, filed 24 Jan 2019.